Stock PLURISTEM THERAPEUTICS
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News Pluristem Therapeutics Nasdaq

Equities

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Pluri : Investor Presentation – Q3 2024
PU
Pluri Announces €1 Million Proof of Concept Agreement to Enhance Global Sustainable Vegetable Supply
AQ
Pluri Inc. Announces ?1 Million Proof of Concept Agreement to Enhance Global Sustainable Vegetable Supply
CI
Pluri Appoints Liat Zalts as CFO
MT
Pluri Inc. Announces CFO Changes, Effective September 30, 2024
CI
Pluri Inc. Announces Executive Changes, Effective September 30, 2024
CI
Pluri : The results of stockholder voting at the 2024 Annual Meeting
PU
Pluri : Material Agreement Form 8 K
PU
Sector Update: Consumer Stocks Ease in Late Afternoon Trading
MT
Sector Update: Consumer
MT
Pluri's Ever After Foods Subsidiary Gets $10 Million Investment; Shares Rise
MT
Pluri Subsidiary Ever After Foods Secured $10 Million Strategic Investment to Solve Cultivated Food Scalability Challenges
AQ
Plurinuva Ltd announced that it expects to receive $10 million in funding from Cfsc Investments, Inc., Interfonda AG, Tnuva Food-Tech Incubator, Limited Partnership, Pluri Biotech Ltd., Pluri Inc., and other investors
CI
U.S. National Institutes of Health Exercises Option to Fund $1.4 Million 2nd Year Budget for Pluri's PLX-R18 Acute Radiation Syndrome Contract
AQ
Pluri : Investor Presentation – Q2 2024
PU
U.S. National Institutes of Health Exercises Option to Fund $1.4 Million 2nd Year Budget for Pluri’s PLX-R18 Acute Radiation Syndrome Contract
AQ
U.S. National Institutes of Health Exercises Option to Fund $1.4 Million 2nd Year Budget for Pluri Inc.?s PLX-R18 Acute Radiation Syndrome Contract
CI
Pluri : Investor Presentation – Q2 2024
PU
Novel Medical Food Solution for the Elderly: Pluri & Wilk Collaborate to Develop Human Breast Milk-Derived Food Production on a Commercial Scale
AQ
Pluri Inc. Announces Strategic Collaboration with Wilk Technologies Ltd. to Develop Human Breast Milk-Derived Food Production on a Commercial Scale
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PLUR Stock
  4. Stock
  5. News Pluristem Therapeutics